211 related articles for article (PubMed ID: 32470706)
21. [Takayasu's arteritis--course, diagnosis and long term results of treatment].
Cybulska I
Pol Arch Med Wewn; 1994 Jun; 91(6):451-60. PubMed ID: 7971466
[TBL] [Abstract][Full Text] [Related]
22. [Large-vessel granulomatous vasculitis during the course of sarcoidosis: Takayasu's arteritis?].
Vaurs C; Ammoury A; Cordel N; Lamant L; Chaufour X; Paul C
Ann Dermatol Venereol; 2009 Dec; 136(12):890-3. PubMed ID: 20004315
[TBL] [Abstract][Full Text] [Related]
23. The renal artery is involved in Chinese Takayasu's arteritis patients.
Chen Z; Li J; Yang Y; Li H; Zhao J; Sun F; Li M; Tian X; Zeng X
Kidney Int; 2018 Jan; 93(1):245-251. PubMed ID: 28863945
[TBL] [Abstract][Full Text] [Related]
24. Development of a colour Doppler ultrasound scoring system in patients of Takayasu's arteritis and its correlation with clinical activity score (ITAS 2010).
Sinha D; Mondal S; Nag A; Ghosh A
Rheumatology (Oxford); 2013 Dec; 52(12):2196-202. PubMed ID: 24014648
[TBL] [Abstract][Full Text] [Related]
25. Updates in the diagnosis and management of Takayasu's arteritis.
Somashekar A; Leung YT
Postgrad Med; 2023 Jan; 135(sup1):14-21. PubMed ID: 36588528
[TBL] [Abstract][Full Text] [Related]
26. Anaemia can be improved by controlling the disease activity of Takayasu's arteritis without iron administration.
Guo Y; Du J; Li T; Gao N; Pan L
Int J Lab Hematol; 2023 Feb; 45(1):112-118. PubMed ID: 36117441
[TBL] [Abstract][Full Text] [Related]
27. Clinical symptoms and associated vascular imaging findings in Takayasu's arteritis compared to giant cell arteritis.
Michailidou D; Rosenblum JS; Rimland CA; Marko J; Ahlman MA; Grayson PC
Ann Rheum Dis; 2020 Feb; 79(2):262-267. PubMed ID: 31649025
[TBL] [Abstract][Full Text] [Related]
28. Risk assessment model for heart failure in Chinese patients with Takayasu's arteritis.
Wang YJ; Ma LL; Liu Y; Yan Y; Sun Y; Wang YS; Dai XM; Ji ZF; Ma LY; Chen HY; Jiang LD
Clin Rheumatol; 2021 Oct; 40(10):4117-4126. PubMed ID: 34021842
[TBL] [Abstract][Full Text] [Related]
29. HADS-depression score is a mediator for illness perception and daily life impairment in Takayasu's arteritis.
Erdal S; Nalbantoğlu B; Gür MB; Yıldırım M; Kılıçarslan A; Kaymaz-Tahra S; Alibaz-Öner F; Yay M; Mumcu G; Direskeneli H
Clin Rheumatol; 2021 Oct; 40(10):4109-4116. PubMed ID: 33839991
[TBL] [Abstract][Full Text] [Related]
30. [The clinical characteristics of Takayasu's arteritis with glomerulonephropathy].
Chen Z; Yang YJ; Li J; Tian XP
Zhonghua Nei Ke Za Zhi; 2018 Feb; 57(2):129-133. PubMed ID: 29397599
[No Abstract] [Full Text] [Related]
31. Assessment of the frequency of cardiovascular risk factors in patients with Takayasu's arteritis.
Alibaz-Oner F; Koster MJ; Unal AU; Yildirim HG; Çikikçi C; Schmidt J; Crowson CS; Makol A; Ytterberg SR; Matteson EL; Direskeneli H; Warrington KJ
Rheumatology (Oxford); 2017 Nov; 56(11):1939-1944. PubMed ID: 28968808
[TBL] [Abstract][Full Text] [Related]
32. Tumor necrosis factor alpha inhibitors in patients with Takayasu's arteritis refractory to standard immunosuppressive treatment: cases series and review of the literature.
Novikov PI; Smitienko IO; Moiseev SV
Clin Rheumatol; 2013 Dec; 32(12):1827-32. PubMed ID: 23995735
[TBL] [Abstract][Full Text] [Related]
33. Takayasu's arteritis in Italian patients.
Vanoli M; Miani S; Amft N; Bacchiani G; Radelli L; Scorza R
Clin Exp Rheumatol; 1995; 13(1):45-50. PubMed ID: 7774102
[TBL] [Abstract][Full Text] [Related]
34. [Revascularization of supra-aortic trunks in Takayasu's arteritis].
Ziadi J; Ben Hammamia M; Sobhi M; Ben Mrad M; Denguir R
J Med Vasc; 2019 Jun; 44(4):260-265. PubMed ID: 31213298
[TBL] [Abstract][Full Text] [Related]
35. [The analysis of the clinical records diagnosed as Takayasu's arteritis with pulmonary vascular involvement].
Dou JB; Gong JN; Ma ZH; Kuang TG; Yang YH
Zhonghua Jie He He Hu Xi Za Zhi; 2016 Aug; 39(8):603-7. PubMed ID: 27523893
[TBL] [Abstract][Full Text] [Related]
36. Crohn's disease and Takayasu's arteritis: are they associated?
Guarino AD; Testa A; Mormile I; Imperatore N; Granata F; Rispo A; De Paulis A; Castiglione F
Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1472-1484. PubMed ID: 33629317
[TBL] [Abstract][Full Text] [Related]
37. Serial analysis of clinical and imaging indices reveals prolonged efficacy of TNF-α and IL-6 receptor targeted therapies in refractory Takayasu arteritis.
Youngstein T; Peters JE; Hamdulay SS; Mewar D; Price-Forbes A; Lloyd M; Jeffery R; Kinderlerer AR; Mason JC
Clin Exp Rheumatol; 2014; 32(3 Suppl 82):S11-8. PubMed ID: 24093733
[TBL] [Abstract][Full Text] [Related]
38. Analysis of predictive factors for treatment resistance and disease relapse in Takayasu's arteritis.
Sun Y; Ma L; Chen H; Kong X; Lv P; Dai X; Ji Z; Yang C; Dai S; Wu L; Zou Y; Lin J; Shi H; Yu Q; Jiang L
Clin Rheumatol; 2018 Oct; 37(10):2789-2795. PubMed ID: 29687289
[TBL] [Abstract][Full Text] [Related]
39. Non-glucocorticoid drugs for the treatment of Takayasu's arteritis: A systematic review and meta-analysis.
Barra L; Yang G; Pagnoux C;
Autoimmun Rev; 2018 Jul; 17(7):683-693. PubMed ID: 29729444
[TBL] [Abstract][Full Text] [Related]
40. Impaired quality of life, disability and mental health in Takayasu's arteritis.
Yilmaz N; Can M; Oner FA; Kalfa M; Emmungil H; Karadag O; Yildiz F; Kimyon G; Yilmazer B; Gerdan V; Bilge SY; Ilhan B; Cobankara V; Kasifoglu T; Cefle A; Kisacik B; Onat AM; Akar S; Onen F; Erken E; Kiraz S; Aksu K; Keser G; Mumcu G; Direskeneli H
Rheumatology (Oxford); 2013 Oct; 52(10):1898-904. PubMed ID: 23873821
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
